Thomas F. Gajewski to Antineoplastic Agents, Alkylating
This is a "connection" page, showing publications Thomas F. Gajewski has written about Antineoplastic Agents, Alkylating.
Connection Strength
0.575
-
Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma. Clin Cancer Res. 2005 Nov 01; 11(21):7861-5.
Score: 0.246
-
Temozolomide for melanoma: new toxicities and new opportunities. J Clin Oncol. 2004 Feb 15; 22(4):580-1.
Score: 0.217
-
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. JAMA. 2014 Jun 18; 311(23):2397-405.
Score: 0.112